Results 251 to 260 of about 4,267,348 (351)

Study on the Influencing Factors of the Migration and Transformation Behavior of Hexavalent Chromium in a Soil-Groundwater System: A Review. [PDF]

Toxics
Zhao X, Hao M, Fan T, Liu A, Feng C.
europepmc   +1 more source

Earth Surface Processes

, 2007
openaire   +1 more source

Earth Surface Processes [PDF]

, 1997
openaire   +1 more source

A Hybrid Signal Processing Approach for Rail Surface Irregularity Detection Using Onboard Axle Box Acceleration Sensors

Reza Naseri, Brennan L. Gedney, Hossein Asgari, Dimitris Rizos   +3 more
openalex   +1 more source

Insights Into the Antigenic Repertoire of Unclassified Synaptic Antibodies

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective We sought to characterize the sixth most common finding in our neuroimmunological laboratory practice (tissue assay‐observed unclassified neural antibodies [UNAs]), combining protein microarray and phage immunoprecipitation sequencing (PhIP‐Seq). Methods Patient specimens (258; 133 serums; 125 CSF) meeting UNA criteria were profiled;
Michael Gilligan, John R. Mills, Paulina Vargas, Naveen K. Paramasivan, Connie E. Lesnick, Eati Basal, Surendra Dasari, James P. Fryer, Shannon R. Hinson, Joseph Laporta, Amy Espinal, Dennis Fitzgerald, Carolina Garcia, Anna E. Morenkova, Paola Pergami, Anna Shah, Andrew Knight, Reghann LaFrance Corey, Vanda A. Lennon, Anastasia Zekeridou, Sean J. Pittock, Divyanshu Dubey, Andrew McKeon   +22 more
wiley   +1 more source

Analysis of Physical Processes in Confined Pores of Activated Carbons with Uniform Porosity. [PDF]

Materials (Basel)
Blachnio M, Zienkiewicz-Strzalka M, Derylo-Marczewska A.   +2 more
europepmc   +1 more source

Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer, Frauke Stascheit, Maximilian Mönch, Paolo Doksani, Carla Dusemund, Meret Herdick, Philipp Mergenthaler, Maike Stein, Amani Suboh, Jutta Schröder‐Braunstein, Guido Wabnitz, Jan D. Lünemann, Sophie Lehnerer, Sarah Hoffmann, Andreas Meisel   +14 more
wiley   +1 more source

Inverse Gas Chromatography for Characterization of Adsorption Ability of Carbon-Mineral Composites for Removal of Antibiotics from Water. [PDF]

Materials (Basel)
Słomkiewicz P, Piekacz K, Dołęgowska S.   +2 more
europepmc   +1 more source

Olink Proteomics Analysis Reveals Heterogeneous Responses to FcRn Blockade in Anti‐AChR Antibody‐Positive Myasthenia Gravis: FGF‐19 as a Novel Biomarker

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to systematically observe the clinical manifestations, immune cell subsets, and dynamic changes in serological indicators in patients with myasthenia gravis (MG) before and after efgartigimod (EFG) treatment. Methods We analyzed the baseline data, laboratory parameters, and lymphocyte subset proportions in MG ...
Tiancheng Luo, Deyou Peng, Zhouao Zhang, Mingjin Yang, Xinyan Guo, Tianyu Ma, Xiaoyu Huang, Mingming Xu, Linlin Fu, Yong Zhang   +9 more
wiley   +1 more source

Effect of Si on the Impact-Abrasive Wear Behavior of Medium-Carbon Low Alloy Steels with Different Microstructure. [PDF]

Materials (Basel)
Wang Z, Cai C.
europepmc   +1 more source